Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126030001 | 12603000 | 1 | I | 20160629 | 20160721 | 20160728 | 20160728 | EXP | FR-PFIZER INC-2016355888 | PFIZER | 56.00 | YR | M | Y | 0.00000 | 20160728 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126030001 | 12603000 | 1 | PS | Zyvoxid | LINEZOLID | 1 | Oral | 600 MG, 2X/DAY | 4800 | MG | Y | 21130 | 600 | MG | FILM-COATED TABLET | BID | |||
126030001 | 12603000 | 2 | SS | ROCEPHINE | CEFTRIAXONE SODIUM | 1 | Intravenous (not otherwise specified) | 2 G, DAILY | Y | 0 | 2 | G | |||||||
126030001 | 12603000 | 3 | SS | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Oral | 500 MG, 3X/DAY | 10500 | MG | Y | 0 | 500 | MG | FILM-COATED TABLET | TID | |||
126030001 | 12603000 | 4 | SS | ROVAMYCINE /00074401/ | SPIRAMYCIN | 1 | Intravenous drip | 2 DF, 3X/DAY | 42 | DF | Y | 0 | 2 | DF | TID | ||||
126030001 | 12603000 | 5 | SS | WELLVONE | ATOVAQUONE | 1 | Oral | 1 DF, 2X/DAY | 14 | DF | Y | 0 | 1 | DF | BID | ||||
126030001 | 12603000 | 6 | SS | COLCHICINE. | COLCHICINE | 1 | Oral | 0.5 MG, DAILY | Y | 0 | .5 | MG | |||||||
126030001 | 12603000 | 7 | C | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | 180 MG, 2X/DAY | 0 | 180 | MG | BID | ||||||||
126030001 | 12603000 | 8 | C | NEORAL | CYCLOSPORINE | 1 | 70 MG, 2X/DAY | 0 | 70 | MG | BID | ||||||||
126030001 | 12603000 | 9 | C | ICAZ | ISRADIPINE | 1 | 5 MG, 3X/DAY | 0 | 5 | MG | TID | ||||||||
126030001 | 12603000 | 10 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
126030001 | 12603000 | 11 | C | NEBIVOLOL. | NEBIVOLOL | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD | ||||||||
126030001 | 12603000 | 12 | C | ARANESP | DARBEPOETIN ALFA | 1 | UNK, MONTHLY | 0 | /month | ||||||||||
126030001 | 12603000 | 13 | C | TARDYFERON | FERROUS SULFATE | 1 | 1 DF, 1X/DAY | 0 | 1 | DF | QD | ||||||||
126030001 | 12603000 | 14 | C | UVEDOSE | CHOLECALCIFEROL | 1 | 1 DF, MONTHLY | 0 | 1 | DF | /month | ||||||||
126030001 | 12603000 | 15 | C | ZYLORIC | ALLOPURINOL | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | QD | ||||||||
126030001 | 12603000 | 16 | C | PENTACARINAT | PENTAMIDINE ISETHIONATE | 1 | Respiratory (inhalation) | 300 MG, MONTHLY | 0 | 300 | MG | /month |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126030001 | 12603000 | 1 | Staphylococcal infection |
126030001 | 12603000 | 2 | Pneumonia |
126030001 | 12603000 | 3 | Pneumonia |
126030001 | 12603000 | 4 | Pneumonia |
126030001 | 12603000 | 5 | Prophylaxis |
126030001 | 12603000 | 6 | Gout |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126030001 | 12603000 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126030001 | 12603000 | Mouth ulceration | |
126030001 | 12603000 | Rash | |
126030001 | 12603000 | Tongue ulceration |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126030001 | 12603000 | 1 | 20160626 | 20160630 | 0 | |
126030001 | 12603000 | 2 | 20160623 | 20160701 | 0 | |
126030001 | 12603000 | 3 | 20160623 | 20160630 | 0 | |
126030001 | 12603000 | 4 | 20160623 | 20160630 | 0 | |
126030001 | 12603000 | 5 | 20160623 | 20160704 | 0 | |
126030001 | 12603000 | 6 | 20160628 | 20160630 | 0 |